ahlam1399
06-28-2016, 10:45 AM
**vartis and Xencor enter into bispecific antibody agreement
ZURICH (Reuters) - **vartis has received rights with Xencor to develop bispecific antibodies for treating cancer.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=siWx4htm1cE:nJxvu3Ki4U0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=siWx4htm1cE:nJxvu3Ki4U0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=siWx4htm1cE:nJxvu3Ki4U0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=siWx4htm1cE:nJxvu3Ki4U0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=siWx4htm1cE:nJxvu3Ki4U0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/siWx4htm1cE
ZURICH (Reuters) - **vartis has received rights with Xencor to develop bispecific antibodies for treating cancer.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=siWx4htm1cE:nJxvu3Ki4U0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=siWx4htm1cE:nJxvu3Ki4U0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=siWx4htm1cE:nJxvu3Ki4U0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=siWx4htm1cE:nJxvu3Ki4U0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=siWx4htm1cE:nJxvu3Ki4U0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/siWx4htm1cE